EBMT 2022: Acquired Aplastic Anemia Shows Increased Nestin+ Niche Numbers, Upregulation of Genes of the Adaptive Immune System Cells and of CXCL12 in Transformation
ASH 2022: 4265: Durable Responses from Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) As First Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL): The Accept Phase Ib/II Single Arm Study